JPML Sends Generic Drug Price-Fixing Suits To Pennsylvania

Law360, New York (April 7, 2017, 7:08 PM EDT) -- The Judicial Panel on Multidistrict Litigation on Thursday said the Eastern District of Pennsylvania is the best place to consolidate lawsuits accusing Mylan, Sandoz Inc. and other pharmaceutical companies of fixing prices on generic drugs, and expanded the case to include eight products instead of only two.

The JPML said that 10 cases by direct purchasers should be consolidated to eliminate duplicative discovery regarding allegations that pharmaceutical companies orchestrated a price-fixing scheme related to their generic brands. Siding with drug wholesaler Rochester Drug Co-Operative Inc., the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.